middle.news
Medical Developments International Accelerates Penthrox Growth with New European Deals
6:15am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Medical Developments International Accelerates Penthrox Growth with New European Deals
6:15am on Monday 2nd of June, 2025 AEST
Key Points
Q3 FY25 revenue of $8.9 million, up $0.3 million year-on-year
Operating cashflow improved to $1.7 million from prior year’s $3.9 million outflow
Penthrox hospital segment demand in Australia up 48% year-to-date
New Penthrox distribution agreements signed with Ethypharm (France) and Labatec (Switzerland)
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Medical Developments International (ASX:MVP)
OPEN ARTICLE